Shared by
beno
Fundamentals
As of: Sep 30 2019
Shares Outstanding: 31.9m
Cash: 2.1m
Current liabilities: 4.87m
Current ratio: 0.485
NWC (total current assets - total current liabilities): -2.5m
Monthly Burn rate (net cash used in operations / months): 1.29m
Estimated current cash: -3.06m
Accumulated deficit: 110m
Book value (Stock holder equity / Shares outstanding): -0.033
Catalysts / News / Painting the picture
Announces joint development of a coronavirus vaccine with Beijing CC-Pharming
Withdraws reverse split intentions
Hopes of plans for plant based COVID-19 vaccine
Needs cash
2020-02-28: S-3 for $100m, not in effect yet
Technical Analysis
-Gapped above 2.25 resistance
-Support above 2.25 almost all day
-Levels: 2.25, 2.50, 2.70
Original Plan / Strategy
FT-15 of 2.25 technical zone
Review
OGT, scaled in three lots (should have done 4 lots) and scaled out on the way up, should have been patient and sold some lots in front of the 2.50 psychological level.
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2020-03-05 09:31:17 | IBIO | buy | $2.309 | long |
| 2020-03-05 09:31:32 | IBIO | buy | $2.280 | long |
| 2020-03-05 09:31:38 | IBIO | buy | $2.250 | long |
| 2020-03-05 09:32:32 | IBIO | sell | $2.370 | long |
| 2020-03-05 09:32:50 | IBIO | sell | $2.402 | long |
| 2020-03-05 09:32:57 | IBIO | sell | $2.420 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!